Cyclopentolate ophthalmic Alternatives Compared
| Cyclopentolate ophthalmic | Atropine ophthalmic | Phenylephrine ophthalmic |
|
|---|
| Cyclopentolate ophthalmic | Atropine ophthalmic | Phenylephrine ophthalmic |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Pupillary Dilation, Refraction - Assessment. May also be prescribed off label for Uveitis. |
Prescribed for Uveitis, Refraction - Assessment, Pupillary Dilation. atropine ophthalmic may also be used for purposes not listed in this medication guide. |
Prescribed for Eye Redness, Pupillary Dilation. phenylephrine ophthalmic may also be used for purposes not listed in this medication guide. |
Choose a suggestion below Pupillary Dilation
|
|||||||||||||||||||||||
| More about Cyclopentolate ophthalmic | More about Atropine ophthalmic | More about Phenylephrine ophthalmic | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Availability | ||||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription and OTC |
||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Cyclopentolate ophthalmic has an average rating of 2.5 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 50% reported a negative effect. |
Be the first to share your experience with this drug. |
Phenylephrine ophthalmic has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See the full cyclopentolate ophthalmic side effects document. |
See the full atropine ophthalmic side effects document. |
See the full phenylephrine ophthalmic side effects document. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all cyclopentolate ophthalmic prices |
View all atropine ophthalmic prices |
View all phenylephrine ophthalmic prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Ak-Pentolate, Cyclogyl, Cylate | Atropine-Care, Atropisol, Atrosulf-1, Isopto Atropine | AK-Dilate, AK-Nefrin, Altafrin, Mydfrin, Neofrin, Refresh Redness Relief | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 16 drugs are known to interact with cyclopentolate ophthalmic:
|
A total of 16 drugs are known to interact with atropine ophthalmic:
|
A total of 88 drugs are known to interact with phenylephrine ophthalmic:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
March 15, 2022 |
N/A |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.